These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 8066608)

  • 1. Portal tolerance in rats: effect of donor cell treatment and timing of administration.
    Tanigawa T; Monden M; Nagano H; Hasuike Y; Gotoh M; Fukuzaki T; Ota H; Yoshida T; Mori T
    Transplant Proc; 1994 Aug; 26(4):1870-1. PubMed ID: 8066608
    [No Abstract]   [Full Text] [Related]  

  • 2. Generation of suppressor cells maintains donor-specific tolerance after intrathymic injection of alloantigen.
    Nakafusa Y; Arima T; Goss JA; Flye MW
    Transplant Proc; 1995 Feb; 27(1):128-9. PubMed ID: 7878881
    [No Abstract]   [Full Text] [Related]  

  • 3. Impact of perioperative portal venous administration of donor lymphocytes on survival of rat cardiac allografts and renal grafts of the mongrel dog.
    Hirakawa K; Yoshimura N; Lee CJ; Yasui H; Ohsaka Y; Hamashima T; Oka T
    Transplant Proc; 1993 Feb; 25(1 Pt 1):346-7. PubMed ID: 8438328
    [No Abstract]   [Full Text] [Related]  

  • 4. Prolonged survival of hepatic and cardiac allografts by i.v. injection of donor spleen cells following splenectomy in rats: possible mechanisms involved in tolerance induced by intraportal injection of donor antigens.
    Nagano H; Monden M; Gotoh M; Tanigawa T; Nakano Y; Tono T; Mori T
    Transplant Proc; 1993 Feb; 25(1 Pt 1):352-3. PubMed ID: 8438331
    [No Abstract]   [Full Text] [Related]  

  • 5. Donor-specific tolerance to cardiac, but not renal, allografts is induced by intrathymic transfer of donor splenocytes.
    Nakafusa Y; Goss JA; Flye MW
    Transplant Proc; 1993 Feb; 25(1 Pt 1):292-4. PubMed ID: 8438305
    [No Abstract]   [Full Text] [Related]  

  • 6. Serum suppressive factor appears to potentiate cardiac allograft survival after portal vein injection of ultraviolet B-irradiated donor spleen cells.
    Yu S; Nakafusa Y; Flye MW
    Transplant Proc; 1993 Feb; 25(1 Pt 1):500-1. PubMed ID: 8438394
    [No Abstract]   [Full Text] [Related]  

  • 7. Intrathymic tolerance induction is based on suppressor cells.
    Kampinga J; Klatter F; Bartels H; Pater J; Nieuwenhuis P; Roser B; Groen H
    Transplant Proc; 1994 Apr; 26(2):725-6. PubMed ID: 8171626
    [No Abstract]   [Full Text] [Related]  

  • 8. Donor-specific transfusion using mitomycin-C treated spleen cells induces significant prolongation of cardiac allograft in rats.
    Tanigawa T; Gotoh M; Nagano H; Ota H; Hasuike Y; Yoshida T; Sakon M; Monden M
    Transplant Proc; 1997; 29(1-2):1149-50. PubMed ID: 9123243
    [No Abstract]   [Full Text] [Related]  

  • 9. Viable antigen-presenting cells are required for induction of intrathymic tolerance.
    Nakafusa Y; Goss JA; Flye MW
    Transplant Proc; 1994 Apr; 26(2):845-6. PubMed ID: 8171684
    [No Abstract]   [Full Text] [Related]  

  • 10. Duration of donor-specific tolerance after intrathymic administration of alloantigen.
    Arima T; Nakafusa Y; Goss JA; Walp LA; Yu S; Flye MW
    Transplant Proc; 1995 Feb; 27(1):136-7. PubMed ID: 7878912
    [No Abstract]   [Full Text] [Related]  

  • 11. Reduction in donor-specific cytotoxic T lymphocytes and prolonged cardiac allograft survival following intrathymic donor splenocyte injection.
    Goss JA; Nakafusa Y; Yu S; Flye MW
    Transplant Proc; 1993 Feb; 25(1 Pt 1):286-8. PubMed ID: 8438302
    [No Abstract]   [Full Text] [Related]  

  • 12. Cyclosporine control of recipient lymphocyte traffic to the heart allograft.
    Maksymowicz M; Olszewski WL
    Transplant Proc; 1996 Dec; 28(6):3441-3. PubMed ID: 8962342
    [No Abstract]   [Full Text] [Related]  

  • 13. Xenograft tolerance induced by intrathymic spleen cell injection.
    Sheffield CD; Hadley GH; Bartlett ST
    Transplant Proc; 1994 Jun; 26(3):1204. PubMed ID: 8029887
    [No Abstract]   [Full Text] [Related]  

  • 14. Pretreatment of recipients with mitomycin-C-treated spleen cells induces significant prolongation of cardiac allograft survival in rats.
    Tanigawa T; Monden M; Gotoh M; Nagano H; Hasuike Y; Fukuzaki T; Akagi K; Yoshida T; Ota H; Mori T
    Transplant Proc; 1994 Dec; 26(6):3359-60. PubMed ID: 7998173
    [No Abstract]   [Full Text] [Related]  

  • 15. Prolongation of islet allografts by pretreatment with intrathymic UV-B donor spleen cells.
    Jin MX; Chowdhury NC; James T; Engelstad K; Hardy MA; Oluwole SF
    Transplant Proc; 1993 Feb; 25(1 Pt 1):291. PubMed ID: 8438304
    [No Abstract]   [Full Text] [Related]  

  • 16. Suppression of hepatic allograft rejection in the rat by mitomycin C-treated donor splenocytes: tissue distribution of donor class I major histocompatibility complex antigen-positive cells in the recipient.
    Goto M; Yamaguchi Y; Hamaguchi H; Hisama N; Miyanari N; Ichiguchi O; Mori K; Shirakusa T; Ogawa M
    Transplant Proc; 1995 Apr; 27(2):1625-7. PubMed ID: 7725428
    [No Abstract]   [Full Text] [Related]  

  • 17. Intrathymic injection of alloantigen may lead to hyperacute rejection and prolonged graft survival of heart allografts in the rat.
    de Bruin RW; van Rossum TJ; Scheringa M; Bonthuis F; IJzermans JN; Marquet RL
    Transplantation; 1995 Nov; 60(9):1061-3. PubMed ID: 7491686
    [No Abstract]   [Full Text] [Related]  

  • 18. Liver sinusoidal passenger lymphocytes reveal suppressive properties and prolong allograft survival.
    Olszewski WL; Jasklowska-Englisz M; Sadowska-Ryffa D; Lukomska B; Maksymowicz M
    Transplant Proc; 1995 Feb; 27(1):194-5. PubMed ID: 7878970
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Different response of intestinal and cardiac allografts to pretreatment with UV-B irradiated donor-specific leukocytes (DL) or DL alone.
    Gundlach M; Oluwole SF; Pohland CC; Broelsch CE; Hardy MA
    Transplant Proc; 1996 Oct; 28(5):2482-3. PubMed ID: 8907913
    [No Abstract]   [Full Text] [Related]  

  • 20. Effects of donor splenocytes treated with mitomycin C on rat hepatic, cardiac, and intestinal allografts.
    Bollinger RB; Yamaguchi Y; Harland RC; Wyble C; Mori K
    Transplant Proc; 1989 Feb; 21(1 Pt 1):213-4. PubMed ID: 2495602
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.